Latest Breaking News On - Klaas bakker - Page 1 : comparemela.com

Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH

Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew orleansUnited kingdomRolf gulliksenKlaas bakkerAmerican society of hematologyAmerican society of hematology meetingEuropean unionGlobal head of corporate communicationsNasdaq stockholmAnnual american societyHematology meetingPeptide drug conjugateChief medicalAmerican societyGlobal head

Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH

STOCKHOLM, Dec. 12, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company.

United statesNew orleansUnited kingdomRolf gulliksenKlaas bakkerAmerican society of hematology meetingAmerican society of hematologyEuropean unionGlobal head of corporate communicationsNasdaq stockholmAnnual american societyHematology meetingPeptide drug conjugateChief medicalAmerican societyGlobal head

Oncopeptides AB: Oncopeptides provides an update from the meeting with FDAs advisory committee ODAC

STOCKHOLM, Sept. 23, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological

United kingdomRolf gulliksenKlaas bakkerJakob lindbergOncologic drugs advisory committeeEuropean unionEuropean commissionDrug administrationGlobal head of corporate communicationsGlobal headCorporate communicationsEuropean economic areaMid capNasdaq stockholm

Oncopeptides provides an update from the meeting with FDAs advisory committee ODAC

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for.

United kingdomRolf gulliksenKlaas bakkerJakob lindbergOncologic drugs advisory committeeEuropean unionEuropean commissionDrug administrationGlobal head of corporate communicationsGlobal headCorporate communicationsEuropean economic areaMid capNasdaq stockholmOncopeptides ab

Oncopeptides AB: Briefing Book for ODAC meeting on benefit/risk profile of Pepaxto now published

STOCKHOLM, Sept. 20, 2022 /PRNewswire/ Oncopeptides AB (publ) (NASDAQ: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological

Rolf gulliksenKlaas bakkerJakob lindbergEuropean unionEuropean commissionDrug administrationGlobal head of corporate communicationsBriefing bookOncologic drugs advisory committeeExecutive vice presidentChief medicalGlobal headCorporate communicationsEuropean economic areaMid capNasdaq stockholm